Such a hormone replacement strategy is also underscored by the presence of an ANP deficiency in human heart failure due to either reduced production and/or increased peptide degradation.86 Therefore, even when plasma levels of NPs are elevated in heart failure and other conditions, pharmacological GC-A/B stimulation may still be beneficial. The gene discussed is NPPA; the disease is heart failure.